日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression

β-酮烯胺共价有机框架纳米平台结合光动力免疫疗法阻断免疫检查点,可抑制胶质母细胞瘤进展。

Yan, Tengfeng; Liao, Qiuye; Chen, Zhihao; Xu, Yang; Zhu, Wenping; Hu, Ping; Zhang, Si; Wu, Yanze; Shu, Lei; Liu, Junzhe; Luo, Min; Shu, Hongxin; Sheng, Yilei; Wang, Li; Xu, Chun; Lei, Chang; Wang, Hongming; Ye, Qingsong; Yang, Li; Zhu, Xingen

Identification of TAP2 as a novel immune target in human cancers: insights from integrated bioinformatics and experimental approaches.

鉴定 TAP2 为人类癌症中的一种新型免疫靶点:来自整合生物信息学和实验方法的见解

Yang Lufei, Gui Jiawei, Sheng Yilei, Liu Junzhe, Wang Chong, Fang Zhansheng, Huang Le, Tu Zewei, Zhu Xingen, Huang Kai

Specific signaling pathways mediated programmed cell death in tumor microenvironment and target therapies

肿瘤微环境中介导程序性细胞死亡的特定信号通路及其靶向治疗

Sun, Chengpeng; Gui, Jiawei; Sheng, Yilei; Huang, Le; Zhu, Xingen; Huang, Kai

Deep learning-assisted detection and segmentation of intracranial hemorrhage in noncontrast computed tomography scans of acute stroke patients: a systematic review and meta-analysis

基于深度学习的急性卒中患者非增强CT扫描颅内出血检测与分割:系统评价和荟萃分析

Hu, Ping; Yan, Tengfeng; Xiao, Bing; Shu, Hongxin; Sheng, Yilei; Wu, Yanze; Shu, Lei; Lv, Shigang; Ye, Minhua; Gong, Yanyan; Wu, Miaojing; Zhu, Xingen

The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker.

细胞衰老调节因子 p16 是一种有前景的癌症预后和免疫检查点抑制剂 (ICI) 治疗生物标志物

Tu Zewei, Wang Xiaolin, Cai Huan, Sheng Yilei, Wu Lei, Huang Kai, Zhu Xingen

Comprehensive analysis of the prognostic implications and functional exploration of PAK gene family in human cancer

对PAK基因家族在人类癌症中的预后意义和功能进行全面分析

Lei, Kunjian; Luo, Min; Tu, Zewei; Lv, Shigang; Liu, Junzhe; Gong, Chuandong; Ye, Minhua; Wu, Miaojing; Sheng, Yilei; Long, Xiaoyan; Li, Jingying; Zhu, Xingen; Huang, Kai